polpharm

Polpharm Plans To Continue Investments In Development Of Biofarm After Takeover

Polish pharmaceutical group Polpharma, which has recently acquired the Romanian drug manufacturer Biofarm in a deal valued at about EUR257 million, says that Romania is one of its strategic markets for growth in Central and Eastern Europe and announces it will...